Oxigenoterapia hiperbárica en la enfermedad por COVID-19 persistente
García Estévez, Daniel Apolinar; López Pérez, Ángel; Gómez Márquez, Hugo.
Med. clín (Ed. impr.)
; 161(11): 498-499, dic. 2023. tab
Artículo en Español | IBECS (España) | ID: ibc-228155
Documentos relacionados
Application of hyperbaric oxygen therapy in diabetic foot ulcers: A meta-analysis.
Effects of Oxygen Therapy on Patients with a Chronic Wound: A Systematic Review and Meta-analysis.
The role of hyperbaric oxygen therapy in Fournier's Gangrene: A systematic review and meta-analysis of observational studies.
Efficacity of hyperbaric oxygen therapy for necrotizing fasciitis in the maxillofacial region: The review of the literature.
Sudden hearing loss and early hyperbaric oxygen therapy: A preliminary study.
Effect of hyperbaric oxygen treatment in central retinal artery occlusion.
Use of hyperbaric oxygen therapy (HBOT) in chronic diabetic wound - A randomised trial.
Hyperbaric oxygen therapy attenuates central sensitization induced by a thermal injury in humans.
Could Hyperbaric Oxygen Be a Solution in the Treatment of Spinal Infections?
The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1α.